Facebook Linkedin Twitter
Inside Precision Medicine AZ to Use Myriad’s myChoice HRD Plus Test in Phase III Trial

Health care organizations

Micrograph of ovarian dysgerminoma
Molecular Dx

AZ to Use Myriad’s myChoice HRD Plus Test in Phase III Trial

0
Man with congenital blindness crossing the street using his cane
News & Features

First AAV-Delivered Gene Therapy for Inherited Disease Approved by FDA

0
The American Clinical Laboratory Association has sued to block proposed 2018 Medicare payment rates for clinical tests calculated under the Protecting Access to Medicare Act (PAMA). [Source: Clinical Center
Molecular Dx

Clinical Lab Group Sues HHS Over Proposed PAMA 2018 Medicare Rates

Alex Philippidis
0
The FDA is vowing to expand its commitment to precision medicine
News & Features

Commitments to Biomarkers, Precision Medicine Will Be Expanded, FDA Vows

0
Ironman-Boxes-PGM-Dx-30Apr2017
Molecular Dx

FDA Approves First NGS Companion Diagnostic that Screens for Multiple Drugs

Chris Anderson
0
Fancis Collins
News & Features

Francis Collins to Stay on as NIH Director

0
Chris Lunt
News & Features

Tech Veteran Named CTO of NIH’s All of Us Research Program

0
Taking blood for test
Molecular Dx

SomaGenics Nabs NIH Grant to Develop cfDNA Platform

0
Scott Gottlieb
News & Features

Scott Gottlieb Confirmed as FDA Commissioner

0
Patient having a mouth swab test
Molecular Dx

FDA Grants Approval for 23andMe’s Direct-to-Consumer Genetic Health Risk Reports

0
1...192021Page 20 of 21

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine